Immune checkpoint inhibitors combined with VEGF/VEGFR-targeted therapy in microsatellite-stable advanced colorectal cancer: clinical advances and the potential for immune-sensitive tumor conversion. [PDF]
Wang R, Zhou X, Yuan M, Wang Z.
europepmc +1 more source
VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities. [PDF]
Mishra A +4 more
europepmc +1 more source
RTMS Mitigates Simulated Spaceflight-Induced Emotional Dysfunction Through VEGFR-2-Mediated Neuroprotection. [PDF]
Liang R +8 more
europepmc +1 more source
New thiazole/coumarin hybrids as EGFR inhibitors with potential VEGFR-2 inhibition (design, synthesis, biological evaluation, and dynamic stimulation). [PDF]
Elshemy SW, Ali TFS, Sayed AM, Abbas SH.
europepmc +1 more source
VEGF-A signalling at the vascular-immune interface: impact of anti-angiogenic agents on cardiovascular homeostasis and anthracycline-induced injury. [PDF]
Salvatorelli E +5 more
europepmc +1 more source
The Emerging Role of VEGF-C and the Lymphatic System in Diuretic Resistance. [PDF]
Zamora-Cervantes LE +5 more
europepmc +1 more source
Beyond Neurovascular Repair: Should Epileptogenesis Inform VEGF Therapy After Intracerebral Hemorrhage? [PDF]
Chapa-Rodriguez A, Medina Y.
europepmc +1 more source
1-Butylindoline-2,3-dione derivatives as potent VEGFR-2 inhibitors: synthesis, mechanistic anticancer studies, and molecular dynamics simulations. [PDF]
El-Naggar M +9 more
europepmc +1 more source
New Chromene Derivatives as Promising VEGFR-2 Inhibitors: Experimental Cytotoxicity and Comprehensive Computational Characterization. [PDF]
Elkady H +9 more
europepmc +1 more source
Diethylene Glycol-Linked Ring-Fused Bis-Azoles: Target-Oriented Synthesis, In Silico Screening, and Antitumor Activity. [PDF]
Al-Hussain SA +6 more
europepmc +1 more source

